Follow
Gabriela L. Bravo Montenegro
Gabriela L. Bravo Montenegro
National Institutes of Health - National Cancer Institute
Verified email at nih.gov
Title
Cited by
Cited by
Year
Effects of tDCS on executive function in Parkinson's disease
D Doruk, Z Gray, GL Bravo, A Pascual-Leone, F Fregni
Neuroscience letters 582, 27-31, 2014
2072014
Acute treatment with 5-HT3 receptor antagonist, tropisetron, reduces immobility in intact female rats exposed to the forced swim test
G Bravo, S Maswood
Pharmacology Biochemistry and Behavior 85 (2), 362-368, 2006
562006
A feasibility study assessing cortical plasticity in chronic neuropathic pain following burn injury
A Santos Portilla, GL Bravo, FK Miraval, MF Villamar, JC Schneider, ...
Journal of burn care & research 34 (1), e48-e52, 2013
442013
Transcranial direct current stimulation reduces food‐craving and measures of hyperphagia behavior in participants with Prader‐Willi syndrome
GL Bravo, AB Poje, I Perissinotti, BF Marcondes, MF Villamar, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 171 …, 2016
432016
Transcranial direct current stimulation in de novo artistic ability after stroke
M Simis, GL Bravo, PS Boggio, M Devido, RJ Gagliardi, F Fregni
Neuromodulation 17 (5), 497-501, 2014
202014
Risk and protective factors for gastric metaplasia and cancer: a hospital-based case-control study in Ecuador
I Salvador, A Mercado, GL Bravo, M Baldeón, M Fornasini
Nutrición hospitalaria 32 (3), 1193-1199, 2015
172015
Therapeutic time window of noninvasive brain stimulation for pain treatment: inhibition of maladaptive plasticity with early intervention
DC Andrade, I Borges, GL Bravo, N Bolognini, F Fregni
Expert review of medical devices 10 (3), 339-352, 2013
172013
A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families
T Donenberg, S George, J Ali, G Bravo, K Hernandez, N Sookar, ...
Breast cancer research and treatment 174, 469-477, 2019
142019
Challenges in antimicrobial stewardship: rapid diagnostics and optimization of therapy among immunocompromised patients
R Rosa, JF Suarez, G Bravo, JA Morillas-Rodriguez, AD Anderson, ...
Open forum infectious diseases 6 (7), ofz239, 2019
82019
Chronic pain following physical and emotional trauma: the station nightclub fire
R Egyhazi, F Fregni, GL Bravo, NHT Trinh, CM Ryan, JC Schneider
Frontiers in neurology 5, 91909, 2014
82014
Immunotherapy in lung cancer
G Bravo Montenegro, S Farid, SV Liu
Journal of surgical oncology 123 (3), 718-729, 2021
72021
Factores de riesgo y protección para metaplasia y cáncer gástrico: estudio de casos y controles hospitalarios en Quito-Ecuador
I Salvador, A Mercado, GL Bravo, M Baldeón, M Fornasini
Nutrición Hospitalaria 32 (3), 1193-1199, 2015
52015
Osimertinib and capmatinib combination therapy to overcome MET Y1003N-mediated resistance in EGFR-mutant NSCLC: a case report
M Wilgucki, V Yeung, G Ho, GLB Montenegro, G Jones, JE Reuss, SV Liu, ...
JTO Clinical and Research Reports 3 (10), 100396, 2022
42022
Transkranielle elektrische Hirnstimulation
J Reis, B Fritsch
Aktuelle Neurologie 44 (08), 561-567, 2017
42017
Safety of high-dose melphalan (200 Mg/M2) as conditioning for autologous stem cell transplantation for myeloma in elderly patients
A Desai, A Beitinjaneh, J Ramdial, R Ali, L Lekakis, D Pereira, E Kimble, ...
Biology of blood and marrow transplantation 23 (3), S133-S134, 2017
32017
P76. 43 Co-occurring genomic alterations and treatment outcomes in patients with EGFR exon 20 insertion positive NSCLC
GB Montenegro, A Vanderwalde, L Raez, J Nieva, R Feldman, ...
Journal of Thoracic Oncology 16 (3), S605-S606, 2021
22021
P21. 07 Immune-Related Adverse Events with Durvalumab Consolidation in a Real-World Cohort of Patients with Non–Small Cell Lung Cancer (NSCLC)
GB Montenegro, M Serzan, A Belouali, P Sackstein, K Chen, S Rao, ...
Journal of Thoracic Oncology 16 (3), S366, 2021
22021
Functional Signatures Revealed by Deep Phenotyping of CMV-Specific CD8+ T Cells Predict Risk of Early CMV Reactivation after Allogeneic Hematopoietic Cell Transplantation
JF Camargo, E Wieder, E Kimble, CL Benjamin, D Kolonias, G Bravo, ...
Biology of blood and marrow transplantation 24 (3), S99, 2018
22018
P1. 14-52 clinical response to osimertinib in a patient with metastatic NSCLC harboring EGFR A763_Y764insFQEA exon 20 insertion mutation: a case report
GB Montenegro, C Kim
Journal of Thoracic Oncology 14 (10), S575-S576, 2019
12019
P2. 01-100 spectrum of EGFR Exon 20 insertion mutations and co-occurring genetic alterations in patients with non-small-cell lung cancer
GB Montenegro, M Nagasaka, P Ma, AR Naqash, H Mamdani, A Spira, ...
Journal of Thoracic Oncology 14 (10), S680, 2019
12019
The system can't perform the operation now. Try again later.
Articles 1–20